Symrise invests in Synergio
Submitted by:
Andrew Warmington
Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio
Seqens opens Boston R&D centre
Submitted by:
Andrew Warmington
French CDMO Seqens has opened its $5 million ‘Seqens Boston R&D Center’ in Devens, Massachusetts
Sumitomo to buy biostimulant firm
Submitted by:
Andrew Warmington
Subject to usual closing conditions, Japan’s Sumitomo Chemical is to acquire FBSciences, a US-based firm
German companies in renewable energy deals
Submitted by:
Andrew Warmington
Lanxess and Evonik have separately signed power purchase agreements (PPAs) with energy companies Engie and
Dow outlines cost savings measures
Submitted by:
Andrew Warmington
Dow has outlined what it described as “a series of targeted actions aligned to its
Cabot investing in CCAs
Submitted by:
Andrew Warmington
Cabot plans to invest about $75-90 million to add 15,000 tonnes/year of conductive carbon additives
Thailand for second Afyren plant
Submitted by:
Andrew Warmington
French greentech firm Afyren has signed a deal with Thailand’s Mitr Phol, the world’s third
OQ expands in carboxylic acids
Submitted by:
Andrew Warmington
OQ Chemicals has begun an optimisation and debottlenecking project for carboxylic acids at its plants
Sai opens HPAPI facility
Submitted by:
Andrew Warmington
In response to an increasing number of projects, notably in oncology, Indian CRDMO Sai Life
ACC challenges regulators on chemical management
Submitted by:
Andrew Warmington
The American Chemistry Council (ACC), the main trade body of the chemicals industry in the